Akros Pharma News and Activities

Akros Pharma is owned by Shionogi.

Shionogi is one of the...

• Forbes Global 2000 (#1450);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Shionogi is a company listed under the stock ticker 4507 (JP).

Shionogi has a direct presence in 5 countries.

Shionogi has 6 subsidiaries including Akros Pharma, Shionogi Europe and Shionogi France.

Acquisition, funding and merger involving Shionogi.

• Shionogi has announced the acquisition of Apnimed  (posted on March 24 2026).

View the org chart displaying its 11 main executives

Most searched biographies at Akros Pharma

• Teppei Higuchi, President and Chief Executive Officer
• Koji Hanaki, Senior Director, Project Management
• Kristin Williams, Senior Director, Human Resources

Popular executive movements at Shionogi

• Takayuki Yamaguchi will join the company as Senior Vice President, Business Development Division on Dec. 1, 2025  (posted on November 3 2025).
• Makoto Kakutani will join the company as Senior Vice President, Central Pharmaceutical Research Institute on Dec. 1, 2025  (posted on November 3 2025).

Create your alert
to follow the executive moves at Akros Pharma.

Shionogi has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Akros Pharma

• News
• News | JT Global Site

Social media about Akros Pharma

• Akros Pharma on Wikipedia, Google News & Yahoo Finance
• Akros Pharma on LinkedIn, X (Twitter) & YouTube